Research Nester released a report titled “Multiple Myeloma Treatment Drugs Market: Global Demand Analysis & Opportunity Outlook 2029″ which delivers detailed overview of the global multiple myeloma treatment drugs market in terms of market segmentation by drug class, therapy, distribution channel, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The multiple myeloma treatment drugs market is projected to grow at a robust CAGR during the forecast period, i.e., 2021-2029. Despite of being a comparatively rare condition, the patient-pool of multiple myeloma is assessed to increase significantly in the coming years, leading to boost the market growth. As per our analysis, more than 34,000 adults in the U.S.A are expected to be diagnosed with multiple myeloma cancer in 2021, rising up from 32,200 incidences in 2020.

On the basis of drug class, the global multiple myeloma treatment drugs market is segmented into immmunomodulatory drugs (IMiDs), proteasome inhibitors, steroids, monoclonal antibodies, and others. The segment for IMiDs is anticipated to hold the largest share in the market in the year 2021 as a result of their high success in showing positive treatment rates.  

Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region, out of which, the market in North America is projected to grow at the highest rate and occupy the largest market share in the year 2021. This can be credited to prominent technological advancements with respect to multiple myeloma treatment, the presence of leading drug manufacturers and high adoption of sophisticated cancer treatments in the region.

Increasing Occurrence of Multiple Myeloma

Numerous researches from several external sources reveal that the total number of deaths from multiple myeloma is expected to grow from 2021 onwards. This increasing number of cases is associated with the rise in number of blood cancer cases in general. Apart from this, growing demand for multiple myeloma therapies, along with the surge in the number of people suffering from obesity, which is also one of the primary causes of cancer, are some of the additional factors projected to drive the market growth.

However, the high cost of multiple myeloma treatment and lack of awareness about cancer treatment in low-income economies are some of the factors estimated to limit the progress of the market.

This report also provides the existing competitive scenario of some of the key players of the global multiple myeloma treatment drugs market which includes company profiling of Bristol-Myers Squibb Company (NYSE: BMY), Amgen Inc. (NASDAQ: AMGN), Johnson & Johnson Services, Inc. (NYSE: JNJ), Merck Sharp & Dohme Corp. (NYSE: MRK), Daiichi Sankyo Company, Limited (TYO: 4568), Pfizer Inc. (NYSE: PFE), F. Hoffmann-La Roche Ltd (SWX: RO), Sanofi-aventis Groupe (EPA: SAN), Novartis International AG (SWX: NOVN), and Pharma Mar, S.A. (BME: PHM). The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global multiple myeloma treatment drugs market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

You need to be a member of Global Risk Community to add comments!

Join Global Risk Community

Votes: 0
Email me when people reply –

[Free COVID-19 Framework] What's the path to recovery look like?

We created a free presentation (attached), which discusses both global and organizational impacts of the COVID-19 pandemic, along with critical actions organizations should take immediately. This presentation introduces a framework that helps regions and organizations navigate a path to recovery via 9 potential scenarios. These scenarios capture outcomes related to GDP impact, public health response, and economic policies. The presentation also breaks down 6 immediate and critical actions…

Read more…
3 Replies · Reply by Boris Agranovich Jan 2, 2021
Views: 110

If risk management is about decision making, are current risk management solutions irrelevant?

Now that the updated COSO and ISO risk management standards emphasize a connection to enterprise objectives and decision making, does this mean ERM and GRC solutions focused on risk registers and regulatory compliance are missing the true value of risk management?Will current risk management solutions evolve to integrate more decision support functionality or will standalone prescriptive analytics and other technology solutions take a more prominent role in enabling risk-informed…

Read more…
3 Replies
Views: 74

A question related to classification of instruments between trading and banking book.

We have an interesting question from one of our members.       "We usually perform OTC FX transactions with clients backed-to-back on the market (with Banks). Now we are going to perform a FX swap (i.e. Spot + forward) JPY/EUR for the Bank account for 1 week at the longest. The purpose is to get EUR place @ CB for LCR compliance purpose (no trading purposes). Bank's Management think that this should be considered as a trading position and therefore be classified within the Bank's trading book.…

Read more…
4 Replies
Views: 180

Plunging oil prices: curse or blessing in disguise?

The recent sudden crash of oil prices has had a major impact on the world economy, leading to many troubled faces in the international arena. The Russians fear the effects of yet another powerful hit on their economy, Venezuela seems to be considering default and the Americans are weary of the consequences for its young and emerging shale oil industry. And then you have the Middle East, where the smallest match is enough to ignite the largest fire. But are these worries really justified or…

Read more…
1 Reply
Views: 42

Introducing the Global Risk Series - Book 1 Risk Management How Tos

Dear GlobalRisk Community member, Our community’s mission is to foster business, networking and educational explorations among members. Learn from some of the top experts in the industry as they clearly explain how to approach the most important Risk management concepts. Check out their expert tips and use the link at the end of each article to navigate back to the website to leave your comment or ask a question. Some of the topics include: How do you Explain Risk Appetite?  How to Prepare a…

Read more…
14 Replies · Reply by Boris Agranovich Sep 12
Views: 470

    About Us

    The GlobalRisk Community is a thriving community of risk managers and associated service providers. Our purpose is to foster business, networking and educational explorations among members. Our goal is to be the worlds premier Risk forum and contribute to better understanding of the complex world of risk.

    Business Partners

    For companies wanting to create a greater visibility for their products and services among their prospects in the Risk market: Send your business partnership request by filling in the form here!